Your browser doesn't support javascript.
loading
A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Occurred in Postchemotherapy of Breast Cancer.
Tong, Jiankun; Aksenov, Sergei; Siegel, Beth M; Wei, Lihong; Rodgers, William H.
Afiliação
  • Tong J; Department of Pathology, New York Presbyterian Queens, 56-45 Main Street, Flushing, NY 11355, USA.
  • Aksenov S; Department of Pathology, New York Presbyterian Queens, 56-45 Main Street, Flushing, NY 11355, USA.
  • Siegel BM; Department of Surgery, Section of Breast Surgery, New York Presbyterian Queens, 58-04 Main Street, Flushing, NY 11355, USA.
  • Wei L; Consultant Hematology & Medical Oncology, Queens Medical Associates, 176-60 Union Tpke # 360, Fresh Meadows, NY 11366, USA.
  • Rodgers WH; Department of Pathology, New York Presbyterian Queens, 56-45 Main Street, Flushing, NY 11355, USA.
Case Rep Hematol ; 2023: 7573037, 2023.
Article em En | MEDLINE | ID: mdl-37457315
ABSTRACT
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematologic malignancy that arises from plasmacytoid dendritic cells. BPDCN typically presents with skin lesions and may involve peripheral blood, bone marrow, lymph nodes, or extranodal sites. It usually arises de novo, and some BPDCN cases are associated with or develop into myeloid neoplasms. Here, we report a case of a 57-year-old female presenting with cervical lymphadenopathy and skin rashes during the COVID-19 pandemic in 2021 following multiple types of postmastectomy therapy for breast cancer. The patient was ultimately diagnosed with BPCDN by lymph node biopsy. To the best of our knowledge, this is the first case report of BPDCN occurring postchemotherapy of breast cancer.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article